[go: up one dir, main page]

NO952904D0 - Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide - Google Patents

Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide

Info

Publication number
NO952904D0
NO952904D0 NO952904A NO952904A NO952904D0 NO 952904 D0 NO952904 D0 NO 952904D0 NO 952904 A NO952904 A NO 952904A NO 952904 A NO952904 A NO 952904A NO 952904 D0 NO952904 D0 NO 952904D0
Authority
NO
Norway
Prior art keywords
tenoyl
oxindole
carboxamide
fluoro
chloro
Prior art date
Application number
NO952904A
Other languages
English (en)
Norwegian (no)
Other versions
NO952904L (no
Inventor
Kelvin Cooper
Thomas Charles Crawford
Bruce H Littman
Christopher J Pazoles
Sally G Ruggeri
Keith D Wilner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/007,217 external-priority patent/US5298522A/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO952904L publication Critical patent/NO952904L/no
Publication of NO952904D0 publication Critical patent/NO952904D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO952904A 1993-01-22 1995-07-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide NO952904D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/007,217 US5298522A (en) 1993-01-22 1993-01-22 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US13827793A 1993-10-18 1993-10-18
PCT/US1994/000096 WO1994016694A1 (fr) 1993-01-22 1994-01-06 Sel de lysine de 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (2)

Publication Number Publication Date
NO952904L NO952904L (no) 1995-07-21
NO952904D0 true NO952904D0 (no) 1995-07-21

Family

ID=26676677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952904A NO952904D0 (no) 1993-01-22 1995-07-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide

Country Status (27)

Country Link
EP (1) EP0680321B1 (fr)
JP (1) JP2711939B2 (fr)
CN (1) CN1116822A (fr)
AP (1) AP468A (fr)
AT (1) ATE171373T1 (fr)
AU (1) AU671533B2 (fr)
BG (1) BG61966B1 (fr)
BR (1) BR9405661A (fr)
CA (1) CA2153050C (fr)
CZ (1) CZ182895A3 (fr)
DE (1) DE69413518T2 (fr)
DK (1) DK0680321T3 (fr)
DZ (1) DZ1748A1 (fr)
ES (1) ES2122236T3 (fr)
FI (1) FI940309A7 (fr)
HU (1) HUT69687A (fr)
IL (1) IL108326A0 (fr)
LV (1) LV10920B (fr)
MA (1) MA23095A1 (fr)
NO (1) NO952904D0 (fr)
NZ (1) NZ261449A (fr)
OA (1) OA10173A (fr)
PL (1) PL309957A1 (fr)
SK (1) SK91395A3 (fr)
UY (1) UY23723A1 (fr)
WO (1) WO1994016694A1 (fr)
YU (1) YU48719B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (fr) * 1996-08-21 1998-03-04 Pfizer Inc. Sels de carboxamides stables à effet prolongé destinés au traitement des maladies articulaires
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio

Also Published As

Publication number Publication date
FI940309L (fi) 1994-07-23
EP0680321B1 (fr) 1998-09-23
NO952904L (no) 1995-07-21
CN1116822A (zh) 1996-02-14
FI940309A7 (fi) 1994-07-23
YU2394A (sh) 1996-10-18
PL309957A1 (en) 1995-11-13
AU671533B2 (en) 1996-08-29
BG61966B1 (bg) 1998-11-30
MA23095A1 (fr) 1994-10-01
DE69413518D1 (en) 1998-10-29
CA2153050A1 (fr) 1994-08-04
ATE171373T1 (de) 1998-10-15
WO1994016694A1 (fr) 1994-08-04
EP0680321A1 (fr) 1995-11-08
JPH08501109A (ja) 1996-02-06
DZ1748A1 (fr) 2002-02-17
DE69413518T2 (de) 1999-02-11
AP468A (en) 1996-03-05
NZ261449A (en) 1996-08-27
ES2122236T3 (es) 1998-12-16
UY23723A1 (es) 1994-06-28
IL108326A0 (en) 1994-04-12
CZ182895A3 (en) 1996-01-17
LV10920B (en) 1996-04-20
AU6019894A (en) 1994-08-15
JP2711939B2 (ja) 1998-02-10
AP9400609A0 (en) 1994-01-31
SK91395A3 (en) 1996-12-04
HUT69687A (en) 1995-09-28
DK0680321T3 (da) 1999-06-14
HU9400176D0 (en) 1994-05-30
BG99767A (bg) 1996-02-28
YU48719B (sh) 1999-07-28
OA10173A (en) 1996-12-18
FI940309A0 (fi) 1994-01-21
CA2153050C (fr) 1998-12-29
LV10920A (lv) 1995-12-20
BR9405661A (pt) 1995-11-21

Similar Documents

Publication Publication Date Title
FI944885A7 (fi) Tölkin perusosa
FI935219L (fi) Kompositioner foer avskiljningskontroll foer med UV-straolning haerdbara agenser av epoxisilikon
FI934971A0 (fi) Anlaeggning foer foerbraenning av spraengaemnen
FI934261L (fi) Foerfarande foer framstaellning av en bilvindruta foersedd med elastram av bestaemd form
FI930657L (fi) Foerfarande foer framstaellning av doseringsformer med foerlaengd aktivaemnesfrigivning
ZA94436B (en) Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
FI930757A7 (fi) Bestrykningsmekanism foer bestrykning av en pappersbana med bestrykningssmet
FI931946L (fi) Alkylering av olefiner med isoparaffiner
FI933814L (fi) Framstaellning av faktor-ix
FI931945L (fi) Alkylering av olefiner med isoparaffiner
FI931322L (fi) Stabilisering av peroxidblekningsvaetskor med klordioxid
NO940190D0 (no) Anvendelse av x-ketoglutarat
MX9206026A (es) Procedimiento de alquilacion de isoalcan-olefinas
NO931399D0 (no) Anvendelse av naturstein
NO952904D0 (no) Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide
FI931997L (fi) Spindeldrift med snabbutloesning av drivspindeln
DK36193D0 (da) Fremgangsmaade
FI925493A0 (fi) Rumselementsystem foer ersaettning av vaotutrymmen med tillfaelligutrymmeni samband med byggnadsarbeten
FI932658A0 (fi) Foerfarande foer framstaellning av viskosfibrer med bandformade tvaersnitt
KR930026760U (ko) Tvcr의 개선된 구성
KR950013629U (ko) 제함기의 제함장치
FI930376L (fi) Tillslutningsanordning av gaengtyp med saekringsorgan
LV10073A (lv) Skidinataju absolutizesanas panemiens
FI932887A0 (fi) Foerbaettrat foerfarande foer framstaellning av 4-nitro-3-trifluorometylanilin
SV1993000010A (es) Preparacion de nuevas sulfonamidocarboxamidas